Does Vitamin D-Binding Protein Predict Response to Vitamin D Supplementation in Term and Preterm Newborns? A Prospective Cohort Study
Journal of Clinical Medicine · 23.06.2026 · 15 (13) · 4856
DOI: 10.3390/jcm15134856 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of Clinical Medicine, online erschienen am 23.06.2026. Verfasst von Burcu Cebeci und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neonatology, Haseki Training and Research Hospital, University of Health Sciences, 34265 Istanbul, Türkiye. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Health Sciences.
Abstract (Originalsprache)
Background
Vitamin D-binding protein (DBP) is the principal carrier of circulating 25-hydroxyvitamin D [25(OH)D] and is independently synthesized by the neonate. Whether neonatal DBP at birth adds predictive value beyond baseline 25(OH)D for supplementation response remains unclear.
Methods
This single-center prospective cohort study enrolled 101 neonates. Neonates with 25(OH)D < 20 ng/mL (supplementation-response cohort; n = 59: 29 preterm, 30 term) received 800 IU/day oral cholecalciferol for 8 weeks; neonates with 25(OH)D ≥ 20 ng/mL served as baseline reference controls (n = 42). Serum 25(OH)D and DBP were measured at baseline and week 8 in the supplementation-response cohort.
Results
Median baseline 25(OH)D was 8.6 [6.7–12.0] ng/mL and median baseline DBP was 4.9 [3.7–8.1] µg/mL. After supplementation, 25(OH)D increased significantly (median Δ = 17.7 ng/mL; p < 0.001), with 55/59 (93.2%) achieving sufficiency. In multivariable regression, gestational age was the strongest independent predictor of Δ25(OH)D (β = −0.440, p = 0.001), followed by baseline 25(OH)D (β = −0.314, p = 0.015); baseline DBP was not significant (β = 0.072, p = 0.551).
Conclusions
Baseline DBP did not independently predict supplementation response. Lower gestational age and lower baseline 25(OH)D were associated with greater increases in 25(OH)D after supplementation, whereas baseline DBP provided no additional predictive value. Supplementation with 800 IU/day for 8 weeks was effective across gestational-age categories. Routine DBP measurement does not appear to provide additional clinical value for guiding neonatal vitamin D supplementation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neonatology, Haseki Training and Research Hospital, University of Health Sciences, 34265 Istanbul, Türkiye.
- Department of Pediatrics, Haseki Training and Research Hospital, University of Health Sciences, 34265 Istanbul, Türkiye.
ORCID-Profile: Burcu Cebeci
Förderung
- University of Health Sciences
Zitieren
APA
Cebeci, B., Arvas, M. E., Kurnaz, D., Çakır, H., Büyükkayhan, D., & Elevli, M. (2026). Does Vitamin D-Binding Protein Predict Response to Vitamin D Supplementation in Term and Preterm Newborns? A Prospective Cohort Study. Journal of Clinical Medicine, 15(13), 4856. https://doi.org/10.3390/jcm15134856
Vancouver
Cebeci B, Arvas ME, Kurnaz D, Çakır H, Büyükkayhan D, Elevli M. Does Vitamin D-Binding Protein Predict Response to Vitamin D Supplementation in Term and Preterm Newborns? A Prospective Cohort Study. Journal of Clinical Medicine. 2026;15(13):4856. doi:10.3390/jcm15134856
BibTeX
@article{Cebeci2026,
author = {Cebeci, Burcu and Arvas, Mehmet Emin and Kurnaz, Dilek and Çakır, Hakan and Büyükkayhan, Derya and Elevli, Murat},
title = {Does Vitamin D-Binding Protein Predict Response to Vitamin D Supplementation in Term and Preterm Newborns? A Prospective Cohort Study},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {13},
pages = {4856},
doi = {10.3390/jcm15134856}
}
EUVIMED